Calliditas Therapeutics Stock (NASDAQ: CALT) stock price, news, charts, stock research, profile.
Open | $40.12 |
Close | $40.12 |
Volume / Avg. | 4.42K / 12.70K |
Day Range | $39.69 - $40.14 |
52 Wk Range | 15.25 - 41.90 |
Market Cap | $1.19B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 83 |
Short Interest | 0.04% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Calliditas Therapeutics (NASDAQ:CALT) through any online brokerage.
Other companies in Calliditas Therapeutics’s space includes: WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS), Phibro Animal Health (NASDAQ:PAHC), Rapport Therapeutics (NASDAQ:RAPP) and ANI Pharmaceuticals (NASDAQ:ANIP).
Calliditas Therapeutics has a consensus price target of $37.50.
The stock price for Calliditas Therapeutics (NASDAQ: CALT) is $44.05 last updated August 30, 2024 at 4:01 PM EDT.
There are no upcoming dividends for Calliditas Therapeutics.
Calliditas Therapeutics’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Calliditas Therapeutics.
Calliditas Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.